Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 2;8(6):e2512487.
doi: 10.1001/jamanetworkopen.2025.12487.

Neurologic and Psychological Outcomes 2 Years After Multisystem Inflammatory Syndrome in Children

Collaborators, Affiliations

Neurologic and Psychological Outcomes 2 Years After Multisystem Inflammatory Syndrome in Children

Caitlin K Rollins et al. JAMA Netw Open. .

Abstract

Importance: Neurologic and psychological sequelae are observed 1 year after hospitalization for multisystem inflammatory syndrome in children (MIS-C), but whether these concerns persist is not known.

Objective: To examine the trajectory of neurologic, psychological, and quality-of-life sequelae up to 2 years after MIS-C.

Design, setting, and participants: This longitudinal cohort study assessed children diagnosed with MIS-C from August 1, 2020, to August 31, 2021, and matched sibling and community controls, when available. The study was conducted 6 to 12 months and 18 to 24 months after discharge from a US or Canadian hospital. Data analysis was performed from May 2024 to January 2025.

Exposure: Hospitalization for MIS-C.

Main outcomes and measures: A central study site remotely administered a structured interview, surveys, neuropsychological assessment, and neurologic examination. Group differences were assessed using generalized estimating equations, accounting for matching. Variables extracted from hospital records included intensive care unit admission and echocardiographic left ventricular ejection fraction (LVEF).

Results: Overall, 95 participants were included in the study; 93 of 108 participants (86%) returned from the year 1 study and 2 participants were added in year 2 (median [IQR] age, 12.6 [11.0-15.7] years; 38 [40%] female and 57 [60%] male). Fifty-nine patients with MIS-C (mean [SD] age, 13.2 [4.0] years; 39 [66%] male) and 36 controls (mean [SD] age, 13.5 [3.5] years; 18 [50%] male) enrolled. In year 2, the MIS-C group was similar to controls on all outcome measures, except they had more somatization symptoms (Behavior Assessment Scale for Children, Third Edition mean [SD] somatization score, 52.1 [13.0] vs 46.5 [8.5]; mean difference, 5.2; 95% CI, 1.3-9.1). Within the MIS-C group, scores generally improved between initial and follow-up evaluations, a finding that was not observed in controls. Eight of 13 children with MIS-C (62%) who had abnormal neurologic examination findings in year 1 had normal examination findings by year 2. Among patients with MIS-C, measures of higher illness severity during hospitalization were associated with worse executive function in year 2 (National Institutes of Health [NIH] List Sort Working Memory Test score, -7.3 points per intensive care unit admission vs not [95% CI, -14.3 to -0.3 points] and -5.8 points per LVEF category change [95% CI, -9.1 to -2.6 points]; verbal fluency switching score, -0.8 points per LVEF category change [95% CI, -1.5 to -0.1 points]).

Conclusions and relevance: In this longitudinal, matched cohort study of children with MIS-C and controls followed up sequentially up to 2 years after hospital discharge, children with MIS-C had more somatic symptoms than control children. Overall, however, patients with MIS-C had improved neurologic and psychological outcomes between the testing intervals, performing similarly to controls on most measures by year 2 follow-up. These findings suggest that these concerns may improve over time.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Son reported receiving royalties from UpToDate during the conduct of the study. Dr Hobbs reported receiving personal fees from UptoDate and Dynamed.com outside the submitted work. Dr Staat reported receiving grants from the National Institutes of Health and Cepheid outside the submitted work. Dr Mazumdar reported that their husband was an employee of Pfizer during the time of the study and directly worked on the COVID-19 vaccine outside the submitted work. Dr Randolph reported receiving grants from the US National Institute of Allergy and Infectious Diseases and personal fees from Inotrem Inc, Thermo Fisher Scientific Inc, and UpToDate outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Group Differences and 2-Year Change in Behavior Assessment Scale for Children, Third Edition Internalizing Problems Scores
The figure shows the year 1 and year 2 scores for 58 patients with multisystem inflammatory syndrome in children (MIS-C) and 39 controls sorted from lowest to highest scores. Lines and arrow reflect the change between year 1 and year 2 scores, where available. Matched controls, where available, are plotted on the same x-axis value as the cases. Solid orange horizontal line reflects the test mean. Dotted orange horizontal line indicates 1 SD worse than the mean; the test defined at-risk threshold.

Comment in

  • doi: 10.1001/jamanetworkopen.2025.12495

Similar articles

  • Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children.
    Rollins CK, Calderon J, Wypij D, Taylor AM, Davalji Kanjiker TS, Rohde JS, Maiman M, Zambrano LD, Newhams MM, Rodriguez S, Hart N, Worhach J, Kucukak S, Poussaint TY, Son MBF, Friedman ML, Gertz SJ, Hobbs CV, Kong M, Maddux AB, McGuire JL, Licht PA, Staat MA, Yonker LM, Mazumdar M, Randolph AG, Campbell AP, Newburger JW; Overcoming COVID-19 Investigators. Rollins CK, et al. JAMA Netw Open. 2023 Jul 3;6(7):e2324369. doi: 10.1001/jamanetworkopen.2023.24369. JAMA Netw Open. 2023. PMID: 37466939 Free PMC article.
  • Severe Pediatric Neurological Manifestations With SARS-CoV-2 or MIS-C Hospitalization and New Morbidity.
    Francoeur C, Alcamo AM, Robertson CL, Wainwright MS, Roa JD, Lovett ME, Stulce C, Yacoub M, Potera RM, Zivick E, Holloway A, Nagpal A, Wellnitz K, Even KM, Brunow de Carvalho W, Rodriguez IS, Schwartz SP, Walker TC, Campos-Miño S, Dervan LA, Geneslaw AS, Sewell TB, Pryce P, Silver WG, Lin JE, Vargas WS, Topjian A, McGuire JL, Domínguez Rojas JA, Tasayco-Muñoz J, Hong SJ, Muller WJ, Doerfler M, Williams CN, Drury K, Bhagat D, Nelson A, Price D, Dapul H, Santos L, Kahoud R, Appavu B, Guilliams KP, Agner SC, Walson KH, Rasmussen L, Pal R, Janas A, Ferrazzano P, Farias-Moeller R, Snooks KC, Chang CH, Iolster T, Erklauer JC, Jorro Baron F, Wassmer E, Yoong M, Jardine M, Mohammad Z, Deep A, Kendirli T, Lidsky K, Dallefeld S, Flockton H, Agrawal S, Siruguppa KS, Waak M, Gutiérrez-Mata A, Butt W, Bogantes-Ledezma S, Sevilla-Acosta F, Umaña-Calderón A, Ulate-Campos A, Yock-Corrales A, Talisa VB, Kanthimathinathan HK, Schober ME, Fink EL; Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID) Investigators. Francoeur C, et al. JAMA Netw Open. 2024 Jun 3;7(6):e2414122. doi: 10.1001/jamanetworkopen.2024.14122. JAMA Netw Open. 2024. PMID: 38857050 Free PMC article.
  • Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
    LaRovere KL, Poussaint TY, Young CC, Newhams MM, Kucukak S, Irby K, Kong M, Schwartz SP, Walker TC, Bembea MM, Wellnitz K, Havlin KM, Cvijanovich NZ, Hall MW, Fitzgerald JC, Schuster JE, Hobbs CV, Halasa NB, Singh AR, Mack EH, Bradford TT, Gertz SJ, Schwarz AJ, Typpo KV, Loftis LL, Giuliano JS Jr, Horwitz SM, Biagas KV, Clouser KN, Rowan CM, Maddux AB, Soma VL, Babbitt CJ, Aguiar CL, Kolmar AR, Heidemann SM, Harvey H, Zambrano LD, Campbell AP, Randolph AG; Overcoming COVID-19 Investigators. LaRovere KL, et al. JAMA Neurol. 2023 Jan 1;80(1):91-98. doi: 10.1001/jamaneurol.2022.3881. JAMA Neurol. 2023. PMID: 36342679 Free PMC article.
  • In-hospital unfavorable outcomes of MIS-C during 2020-2022: a systematic review.
    Alvarado-Gamarra G, Alcalá-Marcos K, Balmaceda-Nieto P, Visconti-Lopez FJ, Torres-Balarezo P, Morán-Mariños C, Velásquez-Rimachi V, Chavez-Malpartida SS, Alva-Díaz C. Alvarado-Gamarra G, et al. Eur J Pediatr. 2024 Dec;183(12):5071-5084. doi: 10.1007/s00431-024-05787-x. Epub 2024 Oct 1. Eur J Pediatr. 2024. PMID: 39349752
  • Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.

References

    1. Feldstein LR, Rose EB, Horwitz SM, et al. ; Overcoming COVID-19 Investigators; CDC COVID-19 Response Team . Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334-346. doi:10.1056/NEJMoa2021680 - DOI - PMC - PubMed
    1. Dufort EM, Koumans EH, Chow EJ, et al. ; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team . Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383(4):347-358. doi:10.1056/NEJMoa2021756 - DOI - PMC - PubMed
    1. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-1608. doi:10.1016/S0140-6736(20)31094-1 - DOI - PMC - PubMed
    1. LaRovere KL, Poussaint TY, Young CC, et al. ; Overcoming COVID-19 Investigators . Changes in distribution of severe neurologic involvement in US pediatric inpatients with COVID-19 or multisystem inflammatory syndrome in children in 2021 vs 2020. JAMA Neurol. 2023;80(1):91-98. doi:10.1001/jamaneurol.2022.3881 - DOI - PMC - PubMed
    1. LaRovere KL, Riggs BJ, Poussaint TY, et al. ; Overcoming COVID-19 Investigators . Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78(5):536-547. doi:10.1001/jamaneurol.2021.0504 - DOI - PMC - PubMed

Supplementary concepts